These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29908344)

  • 61. An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice.
    Vong LB; Tomita T; Yoshitomi T; Matsui H; Nagasaki Y
    Gastroenterology; 2012 Oct; 143(4):1027-36.e3. PubMed ID: 22771506
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A novel metformin derivative, HL010183, inhibits proliferation and invasion of triple-negative breast cancer cells.
    Koh M; Lee JC; Min C; Moon A
    Bioorg Med Chem; 2013 Apr; 21(8):2305-2313. PubMed ID: 23490148
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
    Zhu L; Zhang S; Huan X; Mei Y; Yang H
    Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
    [TBL] [Abstract][Full Text] [Related]  

  • 64. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
    BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Smart drug delivery of p-Coumaric acid loaded aptamer conjugated starch nanoparticles for effective triple-negative breast cancer therapy.
    Mariadoss AVA; Saravanakumar K; Sathiyaseelan A; Karthikkumar V; Wang MH
    Int J Biol Macromol; 2022 Jan; 195():22-29. PubMed ID: 34861273
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface.
    Nelson ER; Li S; Kennedy M; Payne S; Kilibarda K; Groth J; Bowie M; Parilla-Castellar E; de Ridder G; Marcom PK; Lyes M; Peterson BL; Cook M; Pizzo SV; McDonnell DP; Bachelder RE
    Oncotarget; 2016 Dec; 7(51):84030-84042. PubMed ID: 27768598
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo.
    Amaro A; Angelini G; Mirisola V; Esposito AI; Reverberi D; Matis S; Maffei M; Giaretti W; Viale M; Gangemi R; Emionite L; Astigiano S; Cilli M; Bachmeier BE; Killian PH; Albini A; Pfeffer U
    Oncotarget; 2016 Oct; 7(42):68803-68820. PubMed ID: 27626697
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanism of metformin action in MCF-7 and MDA-MB-231 human breast cancer cells involves oxidative stress generation, DNA damage, and transforming growth factor β1 induction.
    Marinello PC; da Silva TN; Panis C; Neves AF; Machado KL; Borges FH; Guarnier FA; Bernardes SS; de-Freitas-Junior JC; Morgado-Díaz JA; Luiz RC; Cecchini R; Cecchini AL
    Tumour Biol; 2016 Apr; 37(4):5337-46. PubMed ID: 26561471
    [TBL] [Abstract][Full Text] [Related]  

  • 69. hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.
    Park S; Sung Y; Jeong J; Choi M; Lee J; Kwon W; Jang S; Park SJ; Kim HS; Lee MH; Kim DJ; Liu K; Kim SH; Dong Z; Ryoo ZY; Kim MO
    Oncotarget; 2017 Jun; 8(23):37115-37127. PubMed ID: 28415749
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo.
    Vecchi L; Alves Pereira Zóia M; Goss Santos T; de Oliveira Beserra A; Colaço Ramos CM; França Matias Colombo B; Paiva Maia YC; Piana de Andrade V; Teixeira Soares Mota S; Gonçalves de Araújo T; Van Petten de Vasconcelos Azevedo F; Soares FA; Oliani SM; Goulart LR
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1368-1382. PubMed ID: 29932988
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its Fe-S clusters.
    Darash-Yahana M; Pozniak Y; Lu M; Sohn YS; Karmi O; Tamir S; Bai F; Song L; Jennings PA; Pikarsky E; Geiger T; Onuchic JN; Mittler R; Nechushtai R
    Proc Natl Acad Sci U S A; 2016 Sep; 113(39):10890-5. PubMed ID: 27621439
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models.
    Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Fujiwara T; Bouvet M; Hoffman RM
    Anticancer Res; 2017 Jan; 37(1):57-60. PubMed ID: 28011473
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases.
    Liang R; Liu L; He H; Chen Z; Han Z; Luo Z; Wu Z; Zheng M; Ma Y; Cai L
    Biomaterials; 2018 Sep; 177():149-160. PubMed ID: 29890364
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antrodia salmonea induces G
    Chang CT; Hseu YC; Thiyagarajan V; Huang HC; Hsu LS; Huang PJ; Liu JY; Liao JW; Yang HL
    J Ethnopharmacol; 2017 Jan; 196():9-19. PubMed ID: 27986611
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer.
    Parvani JG; Gujrati MD; Mack MA; Schiemann WP; Lu ZR
    Cancer Res; 2015 Jun; 75(11):2316-2325. PubMed ID: 25858145
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
    Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
    PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differential sensitivities of triple-negative breast cancer stem cell towards various doses of vitamin C: An insight into the internal antioxidant systems.
    Sen U; Chaudhury D; Shenoy P S; Bose B
    J Cell Biochem; 2021 Apr; 122(3-4):349-366. PubMed ID: 33135276
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Self-Assembling Antioxidants for Ischemia-Reperfusion Injuries.
    Yoshitomi T; Nagasaki Y
    Antioxid Redox Signal; 2022 Jan; 36(1-3):70-80. PubMed ID: 34074133
    [No Abstract]   [Full Text] [Related]  

  • 80. (-)‑Oleocanthal inhibits proliferation and migration by modulating Ca
    Diez-Bello R; Jardin I; Lopez JJ; El Haouari M; Ortega-Vidal J; Altarejos J; Salido GM; Salido S; Rosado JA
    Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):474-485. PubMed ID: 30321616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.